Windtree Therapeutics Shares Are Trading Higher After the Company Announced That the Trial Design of Its SEISMiC Phase 2b Has Been Published by the European Society of Cardiology Heart Failure.
Windtree Therapeutics Shares Are Trading Higher After the Company Announced That the Trial Design of Its SEISMiC Phase 2b Has Been Published by the European Society of Cardiology Heart Failure.
windtree therapeutics股價上漲，因爲該公司宣佈其SEISMiC第20億階段的試驗設計已被歐洲心臟病學會心力衰竭分會發布。
Windtree Therapeutics Shares Are Trading Higher After the Company Announced That the Trial Design of Its SEISMiC Phase 2b Has Been Published by the European Society of Cardiology Heart Failure.
windtree therapeutics股價上漲，因爲該公司宣佈其SEISMiC第20億階段的試驗設計已被歐洲心臟病學會心力衰竭分會發布。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間